Healthcare initial public offerings have outpaced other sectors over the last 12 months, according to Renaissance Capital, which notes there have been 20 Healthcare IPOs in 2015 so far that have brought in total proceeds of $1.5bn.
The IPOs have been rolling in over recent weeks – maybe, it's the spring air that is revitalizing the market. The most notable announcement this week was from AbbVie partner...
The new US FDA vaccine guidelines introduced on 20 May might cause financial woes for Moderna, but overall vaccine makers should not be as impacted as feared.
The Phase II study testing the novel TLR7/8 inhibitor met the primary endpoint in a cohort of patients with cutaneous lupus erythematosus and systemic lupus erythematosus with rash, but did not in patients with SLE.
Coming one day after Boehringer’s underwhelming data, PureTech’s tweaked molecule, deupirfenidone, shows promise in slowing idiopathic pulmonary fibrosis.
